Skip to main content

MoneyWorks4Me

Ajanta Pharma informs about board meeting

23 Jan 2023 Evaluate

 Pursuant to Regulation 29 of the Listing Regulations, Ajanta Pharma has informed that a Meeting of the Board of Directors of the Company will be held on Wednesday, 1st February 2023 to consider and take on record unaudited consolidated & standalone financial results of the Company for the third quarter and nine months ended 31st December 2022.

The above information is a part of company’s filings submitted to BSE.



Peers
Company Name CMP
Sun Pharma. Inds. 1869.30
Dr. Reddys Labs. 1381.75
Cipla 1391.80
Lupin 1955.25
Zydus Lifesciences 1198.20
View more..